PMC:7299399 / 0-1502
Annnotations
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 236-241 | Body_part | denotes | scale | http://purl.obolibrary.org/obo/UBERON_0002542 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 53-61 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T2 | 85-93 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T3 | 207-216 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T4 | 818-826 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T5 | 839-849 | Disease | denotes | infectious | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T6 | 1410-1418 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T40007 | 103-106 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T96339 | 114-115 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T6170 | 508-509 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T5795 | 574-575 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T77715 | 627-633 | http://purl.obolibrary.org/obo/UBERON_0007688 | denotes | fields |
| T58051 | 959-964 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T59166 | 1245-1252 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
| T83753 | 1254-1262 | http://purl.obolibrary.org/obo/NCBITaxon_2 | denotes | bacteria |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 282-291 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T2 | 661-669 | Chemical | denotes | medicine | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T3 | 1043-1056 | Chemical | denotes | nanoparticles | http://purl.obolibrary.org/obo/CHEBI_50803 |
| T4 | 1058-1061 | Chemical | denotes | NPs | http://purl.obolibrary.org/obo/CHEBI_50803 |
| T5 | 1333-1356 | Chemical | denotes | reactive oxygen species | http://purl.obolibrary.org/obo/CHEBI_26523 |
| T6 | 1342-1348 | Chemical | denotes | oxygen | http://purl.obolibrary.org/obo/CHEBI_25805 |
| T7 | 1358-1361 | Chemical | denotes | ROS | http://purl.obolibrary.org/obo/CHEBI_26523 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 1357-1373 | http://purl.obolibrary.org/obo/GO_1903409 | denotes | (ROS) generation |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-70 | Sentence | denotes | Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic |
| T2 | 72-80 | Sentence | denotes | Abstract |
| T3 | 81-337 | Sentence | denotes | The COVID-19 outbreak has fueled a global demand for effective diagnosis and treatment as well as mitigation of the spread of infection, all through large-scale approaches such as specific alternative antiviral methods and classical disinfection protocols. |
| T4 | 338-559 | Sentence | denotes | Based on an abundance of engineered materials identifiable by their useful physicochemical properties through versatile chemical functionalization, nanotechnology offers a number of approaches to cope with this emergency. |
| T5 | 560-898 | Sentence | denotes | Here, through a multidisciplinary Perspective encompassing diverse fields such as virology, biology, medicine, engineering, chemistry, materials science, and computational science, we outline how nanotechnology-based strategies can support the fight against COVID-19, as well as infectious diseases in general, including future pandemics. |
| T6 | 899-1035 | Sentence | denotes | Considering what we know so far about the life cycle of the virus, we envision key steps where nanotechnology could counter the disease. |
| T7 | 1036-1374 | Sentence | denotes | First, nanoparticles (NPs) can offer alternative methods to classical disinfection protocols used in healthcare settings, thanks to their intrinsic antipathogenic properties and/or their ability to inactivate viruses, bacteria, fungi, or yeasts either photothermally or via photocatalysis-induced reactive oxygen species (ROS) generation. |
| T8 | 1375-1456 | Sentence | denotes | Nanotechnology tools to inactivate SARS-CoV-2 in patients could also be explored. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1 | 53-61 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 20 | 1274-1280 | Species | denotes | yeasts | Tax:4932 |
| 21 | 1410-1420 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 22 | 1424-1432 | Species | denotes | patients | Tax:9606 |
| 25 | 1333-1356 | Chemical | denotes | reactive oxygen species | MESH:D017382 |
| 26 | 1358-1361 | Chemical | denotes | ROS | MESH:D017382 |
| 27 | 85-93 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 28 | 207-216 | Disease | denotes | infection | MESH:D007239 |
| 29 | 818-826 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 30 | 839-858 | Disease | denotes | infectious diseases | MESH:D003141 |